Bf integrase genes of hiv-1 circulating in são paulo, brazil, with a recurrent recombination region

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Iamarino, Atila ^a   de Melo, Fernando Lucas ^a   Braconi, Carla Torres ^a   de Andrade Zanotto, Paolo Marinho ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ELVITEGRAVIR; INTEGRASE; RALTEGRAVIR; VIRUS RNA;

ALLELE; ARTICLE; BRAZIL; CHROMOSOME BREAKAGE; CODON; CONTROLLED STUDY; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC RECOMBINATION; GENETIC SELECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN GENE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROTEIN MODIFICATION; RECOMBINANT GENE; RNA STRUCTURE; SUBSTITUTION LINE; VIRUS GENE; CLASSIFICATION; DNA SEQUENCE; ENZYMOLOGY; EPIDEMIC; GENETIC POLYMORPHISM; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR EVOLUTION; PROBABILITY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

BRAZIL; EPIDEMICS; EVOLUTION, MOLECULAR; HIV INFECTIONS; HIV INTEGRASE; HIV-1; HUMANS; MARKOV CHAINS; PHYLOGENY; POLYMORPHISM, GENETIC; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 84859262944     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034324     Document Type: Article

References (34)

1. Bello G, Guimaraes ML, Morgado MG, (2006) Evolutionary history of HIV-1 subtype B and F infections in Brazil. AIDS 20: 763-768.
2. de Souza AC, de Oliveira CM, Rodrigues CL, Silva SA, Levi JE, (2008) Short communication: Molecular characterization of HIV type 1 BF pol recombinants from Sao Paulo, Brazil. AIDS Res Hum Retroviruses 24: 1521-1525.
3. Sanabani S, Kleine Neto W, Kalmar EM, Diaz RS, Janini LM, et al. (2006) Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil. Infect Genet Evol 6: 368-377.
4. Zhang M, Foley B, Schultz AK, Macke JP, Bulla I, et al. (2010) The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology 7: 25.
5. Gonsalez CR, Alcalde R, Nishiya A, Barreto CC, Silva FE, et al. (2007) Drug resistance among chronic HIV-1-infected patients naive for use of anti-retroviral therapy in Sao Paulo city. Virus Res 129: 87-90.
6. De Sa Filho DJ, Sucupira MC, Caseiro MM, Sabino EC, Diaz RS, et al. (2006) Identification of two HIV type 1 circulating recombinant forms in Brazil. AIDS Res Hum Retroviruses 22: 1-13.
7. Sa Filho DJ, Sanabani S, Diaz RS, Munerato P, Brunstein A, et al. (2005) Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil. AIDS Res Hum Retroviruses 21: 145-151.
8. Sanabani S, Neto WK, de Sa Filho DJ, Diaz RS, Munerato P, et al. (2006) Full-length genome analysis of human immunodeficiency virus type 1 subtype C in Brazil. AIDS Res Hum Retroviruses 22: 171-176.
9. Grinsztejn B, Nguyen BY, Katlama C, Gatell JM, Lazzarin A, et al. (2007) Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial. Lancet 369: 1261-1269.
10. DeJesus E, Berger D, Markowitz M, Cohen C, Hawkins T, et al. (2006) Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients. J Acquir Immune Defic Syndr 43: 1-5.
11. Engelman A, Craigie R, (1992) Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J Virol 66: 6361-6369.
12. Kulkosky J, Jones KS, Katz RA, Mack JP, Skalka AM, (1992) Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol 12: 2331-2338.
13. Pommier Y, Johnson AA, Marchand C, (2005) Integrase inhibitors to treat HIV/AIDS. Nat Rev Drug Discov 4: 236-248.
14. Lataillade M, Chiarella J, Kozal MJ, (2007) Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance. Antivir Ther 12: 563-570.
15. Malet I, Delelis O, Valantin MA, Montes B, Soulie C, et al. (2008) Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro. Antimicrob Agents Chemother 52: 1351-1358.
16. Ministério da Saúde do Brasil, Secretaria de Vigilância em Saúde, Programa Nacional de DST e AIDS (2010) Boletim Epidemiológico. Ano VII n0 01 01/12/2010 ed: Brasília.
17. Passaes CP, Guimaraes ML, Bello G, Morgado MG, (2009) Near full-length genome characterization of HIV type 1 unique BC recombinant forms from Southern Brazil. AIDS Res Hum Retroviruses 25: 1339-1344.
18. Arruda LB, Fonseca LA, Duarte AJ, Casseb J, (2010) Genetic diversity on the integrase region of the pol gene among HIV type 1-infected patients naive for integrase inhibitors in Sao Paulo City, Brazil. AIDS Res Hum Retroviruses 26: 105-107.
19. Bruselles A, Rozera G, Bartolini B, Prosperi M, Del Nonno F, et al. (2009) Use of massive parallel pyrosequencing for near full-length characterization of a unique HIV Type 1 BF recombinant associated with a fatal primary infection. AIDS Res Hum Retroviruses 25: 937-942.
20. Pardini MI, Jamal LF, Durigon EL, Massad E, Perez JF, et al. (2008) Boosting virology in Brazil. PLoS Biol 6: e57.
21. Van Laethem K, Schrooten Y, Covens K, Dekeersmaeker N, De Munter P, et al. (2008) A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes. J Virol Methods 153: 176-181.
22. Schultz AK, Zhang M, Leitner T, Kuiken C, Korber B, et al. (2006) A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomes. BMC Bioinformatics 7: 265.
23. Zhang M, Schultz AK, Calef C, Kuiken C, Leitner T, et al. (2006) jpHMM at GOBICS: a web server to detect genomic recombinations in HIV-1. Nucleic Acids Res 34: W463-W465.
24. Schultz AK, Zhang M, Bulla I, Leitner T, Korber B, et al. (2009) jpHMM: Improving the reliability of recombination prediction in HIV-1. Nucleic Acids Res 37: W647-W651.
25. Zwickl DJ, (2006) Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion [Doctoral Thesis] Austin The University of Texas.
26. Shafer RW, (2006) Rationale and uses of a public HIV drug-resistance database. J Infect Dis 194 (Suppl 1): S51-58.
27. Pond SLK, Posada D, Gravenor MB, Woelk CH, Frost SDW, (2006) Automated phylogenetic detection of recombination using a genetic algorithm. Mol Bio Evol 23: 1891-1901.
28. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW Jr, et al. (2009) Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460: 711-716.
29. Ceccherini-Silberstein F, Malet I, D'Arrigo R, Antinori A, Marcelin AG, et al. (2009) Characterization and structural analysis of HIV-1 integrase conservation. AIDS Rev 11: 17-29.
30. Maertens GN, Hare S, Cherepanov P, (2010) The mechanism of retroviral integration from X-ray structures of its key intermediates. Nature 468: 326-329.
31. Bouyac-Bertoia M, Dvorin JD, Fouchier RA, Jenkins Y, Meyer BE, et al. (2001) HIV-1 infection requires a functional integrase NLS. Mol Cell 7: 1025-1035.
32. Magiorkinis G, Paraskevis D, Vandamme AM, Magiorkinis E, Sypsa V, et al. (2003) In vivo characteristics of human immunodeficiency virus type 1 intersubtype recombination: determination of hot spots and correlation with sequence similarity. J Gen Virol 84: 2715-2722.
33. Thomson MM, Najera R, (2005) Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. AIDS Rev 7: 210-224.
34. McCutchan FE, (1999) Global Diversity in HIV. In: Crandall KA, editors. The evolution of HIV Baltimore The Johns Hopkins University Press pp. 41-104.